Target intelligence / Profile preview

MicroRNA 4260 (MIR4260)

Target
MIR4260
Molecular classification
microRNA, non-coding RNA, regulatory RNA, other
01

Overview

MicroRNA 4260 (MIR4260) is a short (~20-24 nucleotides) non-coding RNA classified as a microRNA that regulates gene expression in multicellular organisms at the post-transcriptional level by affecting mRNA stability and translation[1][3]. MIR4260 is transcribed by RNA polymerase II as part of a primary transcript, processed through the canonical microRNA biogenesis pathway, and loaded into the RNA-induced silencing complex (RISC) where it exerts its gene-silencing activities, typically causing translational repression or degradation of its target mRNAs[1][2][3]. MIR4260 may be involved in diseases such as severe junctional epidermolysis bullosa, but its precise biological functions and therapeutic relevance remain incompletely characterized[1]. As with other microRNAs, it may partake in the regulation of diverse cell biological processes, but there is currently no evidence to support it being a direct therapeutic target, and no drugs or specific biomarkers are established for this molecule[1][3].

Other names
hsa-mir-4260MIR4260
02

Biological functions

Post-transcriptional regulation of gene expressionmRNA destabilizationtranslational inhibitiongene silencingcell-cell communicationother
03

Disease associations

Epidermolysis bullosa junctional 1B severeJunctional epidermolysis bullosapotentially other roles by analogy with microRNA familyother
04

Safety considerations

No direct safety concerns reported; general challenges in targeting microRNAs include off-target effects and delivery[1][3].
05

Biomarkers

Potential as circulating biomarker (by analogy to other microRNAs), but no specific evidence for MIR4260 as biomarker found

Beyond the preview

Go deeper on MicroRNA 4260 (MIR4260).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4260 (MIR4260).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call